Dutch Biotech fighting ALS and other neuro-degenerative diseases gets European backing
The European Investment Bank (EIB) has signed a €30 million convertible loan agreement with Amsterdam-based VectorY Therapeutics, a clinical-stage biotechnology company developing a novel treatment for neurodegenerative diseases. The financing, supported by the European Commission’s InvestEU programme, will help accelerate the development of VectorY’s vectorised antibody platform, which can help to better treat neuro-degenerative diseases, and expand its pipeline. The EIB financing is part of a broader financing syndicate comprised of new investors and existing shareholders.
Source: European Investment Bank.
Read the original at the source: https://www.eib.org/en/press/all/2026-413-dutch-biotech-fighting-als-and-other-neuro-degenerative-diseases-gets-european-backing
Officially imported this from European Investment Bank’s own source. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- European Investment Bank — imported from official source
- Official source
- https://www.eib.org/en/press/all/index.rss RSS
- Imported
- November 11, 2026 13:01
- Versions
- 1 recorded
- Identity
-
https://www.eib.org/en/press/all/2026-413-dutch-biotech-fighting-als-and-other-neuro-de...